Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
How Deadly Is Breast Cancer Worldwide and What Factors Affect Its Impact?
How Deadly Is Breast Cancer Worldwide and What Factors Affect Its Impact? 2

Globally, cancer remains a significant health concern. It is the most common cancer among women. In 2022, over 2.3 million new cases and about 670,000 deaths were reported.

This disease affects many people and communities around the world. The disparities in survival rates are very clear. They show us the importance of understanding what makes breast cancer deadly.

At Liv Hospital, we aim to bring hope. We do this by providing top-notch care. Our goal is to tackle the global effects of this disease and help improve patient outcomes everywhere.

Key Takeaways

  • Over 2.3 million new cases of cancer are diagnosed among women globally each year.
  • Approximately 670,000 deaths occur annually due to this disease.
  • Disparities in survival rates are significant across different regions.
  • Liv Hospital is dedicated to providing world-class healthcare with complete support for international patients.
  • Understanding the factors that affect the deadliness of this disease is key to better patient outcomes.

The Global Burden of Breast Cancer

Global Burden of Breast Cancer
How Deadly Is Breast Cancer Worldwide and What Factors Affect Its Impact? 3

Breast cancer is becoming more common worldwide, affecting global health greatly. It is one of the top cancers in women globally. The numbers of new cases and those living with breast cancer are going up.

Current Worldwide Statistics

Let’s look at the latest numbers. Breast cancer is a big part of new cancer cases every year. The global incidence of breast cancer is high, with over 2 million new cases each year.

  • Breast cancer is the most common cancer in women worldwide.
  • The global incidence of breast cancer has been steadily increasing over the past few decades.
  • There are significant geographical variations in breast cancer incidence rates.

Projected Trends Through 2050

Looking to 2050, the outlook is concerning. The global incidence of breast cancer is expected to hit 3.2 million new cases yearly. Deaths from breast cancer could reach 1.1 million annually. Changes in demographics, lifestyle, and better detection methods are driving this increase.

For more on breast cancer by age, visit this page. It shows which age groups are most affected.

Understanding Breast Cancer as a Disease

Breast Cancer as a Disease
How Deadly Is Breast Cancer Worldwide and What Factors Affect Its Impact? 4

The fight against breast cancer starts with knowing what it is. It’s not just one disease but a group of them that start in the breast. We’ll look at what makes breast cancer, its types, and how it’s classified.

What Defines Breast Cancer

Breast cancer happens when cells in the breast grow out of control and form a tumor. This tumor can be non-cancerous or cancerous. The bad kind, called malignant, can spread to other parts of the body.

Key characteristics of breast cancer include:

  • Abnormal cell growth: Uncontrolled cell division leading to tumor formation.
  • Invasion and metastasis: The ability of cancer cells to invade nearby tissues and spread to distant organs.

Types and Classifications

Breast cancer is sorted by where the tumor is and the type of cells it affects. The main types are:

  • Ductal carcinoma: Begins in the milk ducts of the breast.
  • Lobular carcinoma: Starts in the lobules (milk-producing glands) of the breast.

It’s also sorted by proteins or genes. For example, some cancers are HER2-positiveor hormone receptor-positive.

Type of Breast CancerDescriptionPrevalence
Ductal Carcinoma In Situ (DCIS)Non-invasive cancer where cells are contained in the milk ducts.Common, often detected through mammography.
Invasive Ductal Carcinoma (IDC)Cancer that starts in the milk ducts and invades surrounding breast tissue.Most common type, accounts for majority of breast cancer diagnoses.
Invasive Lobular Carcinoma (ILC)Cancer that begins in the lobules and spreads to nearby tissues.Second most common type, can be harder to detect.

Knowing these classifications helps doctors choose the best treatment. As we learn more about breast cancer, understanding its details is key.

Mortality Rates: Is Breast Cancer Fatal?

Breast cancer is a major health issue worldwide. Its death rates show how big of a problem it is. We look at global death numbers and survival rates by stage to see how deadly it is.

Global Death Statistics

In 2022, about 670,000 people died from breast cancer globally. This number shows how serious the disease is. It shows we need to keep working on finding it early and treating it well.

Survival Rates by Stage

Survival rates for breast cancer change a lot based on when it’s found. Finding it early is key to living longer. If caught early, the 5-year survival rate is much better than if found later.

Early detection is key to better survival rates. Screening and awareness help doctors find and treat breast cancer better.

The data on survival rates by stage shows how important early treatment is. It’s important for people to know the risks and get screened early.

Geographical Distribution of Breast Cancer

Breast cancer rates vary greatly around the world. This shows that many factors influence its occurrence. These factors are not the same everywhere.

High-Incidence Regions

In developed countries, like North America and Western Europe, breast cancer is more common. These places have some of the highest breast cancer numbers worldwide. For example, the United States, Belgium, and Denmark have rates much higher than the global average.

Lifestyle, diet, and reproductive choices in these countries might play a role. Also, better screening and diagnosis lead to more cases being found.

Low-Incidence Regions

On the other hand, many developing countries in Africa and Asia have lower rates. But, it’s important to remember that these numbers might not be fully accurate. Countries like India and those in Sub-Saharan Africa have lower global incidence of breast cancer rates.

The big difference in rates between these regions shows we need different health strategies. We also need to improve healthcare access.

Correlation with Human Development Index

Studies have found a link between breast cancer rates and the Human Development Index (HDI). Countries with a higher HDI tend to have more breast cancer. This suggests that lifestyle and reproductive changes linked to development increase the risk.

Understanding this link is key to creating effective health interventions. It helps us tailor healthcare policies to meet the needs of different populations worldwide.

Looking at the rate of breast cancer globally, we see both genetics and environment matter. By studying these factors and where they are found, we can grasp the global impact of breast cancer better.

Demographic Factors Affecting Breast Cancer Impact

Breast cancer affects different groups in different ways. This shows we need to focus our efforts. We’ll look at how age, race, ethnicity, and money status change breast cancer risks and results.

Age Distribution

Age is a big factor in breast cancer risk. Most cases happen in women over 50. Knowing how age affects risk helps us make better screening plans. For example, the American Cancer Society says women should start screenings at 45 if they’re at average risk.

But younger women can also get breast cancer. Some genetic factors and family history can raise their risk. We need to think about these when we look at overall risk.

Racial and Ethnic Disparities

There are big differences in breast cancer rates and deaths by race and ethnicity. For example, African American women often get more aggressive breast cancer at a younger age than white women. This shows we need special screening and treatment plans.

Being from a certain ethnic group can also change breast cancer risk. Research shows different ethnic groups have different genetic risks. It’s important to make prevention and treatment plans that fit each culture.

Socioeconomic Influences

Socioeconomic status (SES) also affects breast cancer outcomes. Women from lower SES backgrounds often have trouble getting to breast cancer care on time. This leads to late diagnosis and worse results. We need to work on making healthcare more accessible and raising awareness.

Also, SES can influence lifestyle choices and environmental exposures that raise breast cancer risk. We must think about these when we create public health programs to lower breast cancer rates and improve survival.

How To Understand Breast Cancer Risk Factors

To understand why breast cancer is deadly, we need to know its risk factors. It’s a complex disease influenced by genetics, hormones, and lifestyle. Knowing these factors helps in preventing, detecting early, and managing the disease.

Genetic and Family History

Genetics play a big role in breast cancer. Mutations in BRCA1 and BRCA2 genes raise the risk a lot. Women with a family history of breast cancer, like parents or siblings, are at higher risk. Genetic testing can find these mutations early, helping in prevention.

Genetic FactorRisk LevelRecommendation
BRCA1 MutationHighGenetic counseling and enhanced screening
BRCA2 MutationHighGenetic counseling and enhanced screening
Family HistoryModerate to HighRegular screening and risk assessment

Hormonal Influences

Hormones, like estrogen, are key in breast cancer. Early menstruation, late menopause, and hormone therapy increase estrogen levels. This can raise the risk of breast cancer. Knowing these hormonal effects helps in assessing and preventing risk.

Lifestyle Factors

Lifestyle choices also affect breast cancer risk. Drinking alcohol, being overweight, and not exercising can increase risk. A healthy lifestyle, like eating well and exercising, can lower these risks.

Understanding breast cancer risk factors helps us prevent and detect it early. This knowledge lets us make better health choices. It can help reduce the impact of breast cancer.

Global Prevalence and Lifetime Risk

It’s key to know how common breast cancer is worldwide. We must look at current numbers and what’s expected in the future. This helps us fight this disease better.

Worldwide Prevalence Statistics

Breast cancer is the top cancer in women globally, with big differences in how common it is. The World Health Organization (WHO) says over 2.3 million new cases were found in 2020. This makes up about 11.7% of all cancers worldwide.

Many things affect how common breast cancer is, like where you live, your genes, and your lifestyle. For example, North America and Western Europe have more cases than many African and Asian countries. But, in many poor and middle-income countries, more people are getting breast cancer because of lifestyle changes and how they have children.

Lifetime Risk Assessment

The chance of getting breast cancer changes a lot depending on where you are. In the U.S., a woman has about a 1 in 8 chance of getting breast cancer. But in some poor countries, the chance is lower, but more people die from it because they get diagnosed too late and can’t get treatment.

Many things can raise your risk, like:

  • Genetic mutations, such as BRCA1 and BRCA2
  • Family history of breast cancer
  • Hormonal influences, such as early menarche and late menopause
  • Lifestyle factors, including alcohol consumption and lack of physical activity

Knowing these risk factors helps us find and prevent breast cancer early. We need to keep talking about breast cancer and support screening programs. This way, we can lessen the impact of this disease worldwide.

Early Detection and Its Effect on Mortality

Early detection of breast cancer is key to saving lives. It greatly affects how well we can treat the disease. Thanks to screening programs, many people are living longer and better lives.

Screening Programs Worldwide

Screening programs are vital for catching breast cancer early. These efforts vary around the world. Countries with strong programs often see better survival rates.

Effective screening methods include:

  • Mammography, which catches cancer early.
  • Clinical breast examination by doctors to spot issues.
  • Breast self-examination to help people check their own breasts.
Screening MethodFrequencyAge Group
MammographyAnnual40+
Clinical Breast ExaminationAnnual20+
Breast Self-ExaminationMonthly20+

Impact of Early vs. Late Diagnosis

Early detection makes a huge difference in fighting breast cancer. It leads to better treatment and lower death rates. Late diagnosis means tougher treatments and worse results.

Early detection boosts survival chances and reduces harsh treatments. This improves patients’ lives. It’s important to spread awareness and encourage people to get screened.

By understanding early detection’s benefits and joining screening efforts, we can lower death rates. We urge everyone to take care of their breast health.

Treatment Access and Its Impact on Survival

Getting the right breast cancer treatment is key to survival worldwide. The quality and availability of care differ greatly in different places. This affects how well patients do.

Global Disparities in Treatment

There’s a big problem with unequal breast cancer treatment around the world. In many poor countries, getting effective treatments is hard. This is because of money issues, lack of healthcare, and not enough doctors.

This unfairness leads to different survival rates. People in richer countries usually do better because they get treated sooner and with better methods. We need to fix this so everyone gets fair care, no matter where they are.

Innovative Therapies and Their Availability

New treatments for breast cancer have brought hope to many. These include targeted drugs, immunotherapies, and new surgery methods. But, not everyone can get these innovative therapies.

We’re working to make these life-saving treatments more available. We’re doing this through global partnerships, sharing technology, and training more doctors. Our goal is to make sure everyone gets the care they need.

As we keep moving forward, we must find ways to make treatment more accessible. We need to invest in healthcare, spread the word, and fund research for new treatments.

Prevention Strategies and Public Health Initiatives

Public awareness and preventive measures are key in fighting breast cancer. A broad approach is needed, including global campaigns and preventive steps.

Global Awareness Campaigns

Global campaigns are essential in teaching people about breast cancer risks and symptoms. They help spread the word through social media, community events, and healthcare partnerships.

These efforts not only teach about screenings but also offer support to those with breast cancer. By increasing awareness, more women can get screened early, leading to better treatment outcomes.

Preventive Measures and Policies

Preventive steps are also critical in lowering breast cancer rates. We push for policies that support healthy living, like diet and exercise programs. We also work to reduce exposure to risk factors.

The table below shows some preventive actions and their effects on breast cancer risk:

Preventive MeasurePotential Impact
Regular ExerciseReduces risk by 10-20%
Maintaining a Healthy WeightReduces risk by 10-15%
Limiting Alcohol ConsumptionReduces risk by 5-10%

By taking these steps and supporting public health efforts, we can greatly reduce breast cancer worldwide.

Conclusion: The Future of Breast Cancer Management Worldwide

Looking at breast cancer globally, we see progress but also challenges. The question “will breast cancer kill you” is a harsh reality for many. It shows we need to keep raising awareness and taking action.

Breast cancer is complex, with many factors at play. Its fatality often depends on when it’s found and the treatment available. To improve, we need better research, early detection, and access to new treatments.

We must focus on global awareness, prevention, and support policies. This way, we can help more people and lower breast cancer deaths. The fight against breast cancer is a team effort. Everyone, from doctors to policymakers, has a role to play.

What is breast cancer and how is it defined?

Breast cancer is a disease where abnormal cells grow out of control in the breast. It’s a complex issue with different types based on the tumor’s location, behavior, and genetics.

How deadly is breast cancer worldwide?

Breast cancer is a major cause of death worldwide. It has a big impact on death rates, mainly in low- and middle-income countries. This is because these places often have limited access to screening and treatment.

What are the global statistics on breast cancer prevalence?

Breast cancer is the most common cancer in women, with over 2 million new cases every year. The rate of breast cancer varies by region, with higher rates in developed countries.

What are the risk factors associated with breast cancer?

Several factors increase the risk of breast cancer. These include genetic mutations, family history, hormonal influences, and lifestyle choices like obesity and alcohol use.

How does early detection impact breast cancer survival rates?

Early detection through screening greatly improves survival chances. It allows for diagnosis at an early stage, when treatment is more effective.

What is the correlation between breast cancer incidence and the Human Development Index?

There’s a link between breast cancer rates and the Human Development Index. Countries with higher HDI scores tend to have more cases of breast cancer. This is likely due to lifestyle, screening practices, and healthcare access differences.

Are there any demographic factors that affect breast cancer risk and outcomes?

Yes, demographic factors like age, race, ethnicity, and socioeconomic status can affect breast cancer risk and outcomes. Some groups face disparities in care and survival rates.

What is the lifetime risk of developing breast cancer?

The risk of developing breast cancer varies. It depends on genetic predisposition, family history, and lifestyle. Some women are at higher risk than others.

How does access to treatment impact breast cancer survival rates?

Access to effective treatment is key to improving survival rates. Disparities in care lead to differences in outcomes across regions and populations.

What are the global initiatives for breast cancer prevention and control?

Global efforts include awareness campaigns, screening programs, and policies. These aim to promote early detection, improve care access, and reduce risk factors.

Is breast cancer fatal, and can it be prevented?

Breast cancer can be fatal, but early detection and treatment can improve survival. Prevention strategies, like lifestyle changes and risk reduction, can also lower the risk of breast cancer.

What is the global incidence of breast cancer, and how is it projected to change?

Breast cancer is a significant global issue, with over 2 million new cases each year. The number of cases is expected to grow, mainly in low- and middle-income countries, due to demographic changes and longer life expectancy.

References

  1. International Agency for Research on Cancer. (2025, February). Press Release 361: Breast cancer cases and deaths are projected to rise globally. Retrieved from https://www.iarc.who.int/wp-content/uploads/2025/02/pr361_E.pdf
  2. Kim, J., Harper, A., McCormack, V., Sung, H., Houssami, N., Morgan, E., et al. (2025, February 24). Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nature Medicine. https://doi.org/10.1038/s41591-025-03502-3 Nature+1
  3. National Breast Cancer Foundation / National Breast Cancer Organization. (n.d.). Breast Cancer Facts. Retrieved from https://www.nationalbreastcancer.org/breast-cancer-facts/
  4. Stop Breast Cancer. (n.d.). Facts & Figures. Retrieved from https://www.stopbreastcancer.org/information-center/facts-figures/
  5. American Cancer Society. (2024). Breast Cancer Facts & Figures 2024. Retrieved from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2024/breast-cancer-facts-and-figures-2024.pdf

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75